Catalyst Pharmaceuticals, Inc. - Common Stock — Statistiche Finanziarie Trimestrali (NASDAQ:CPRX) | MetaTrader

Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Flusso di cassa derivante dalle attività operative 70.88 M60.04 M71.3 M32.44 M44.89 M59.59 M 208.21 M Flussi di cassa derivanti dalle attività di investimento -88 K0-26 K0-32 K-27 K -85 K Liquidità derivante dalle attività di finanziamento 4.43 M3.06 M872 K4.65 M-25.58 M-12.87 M -32.93 M Liquidità libera 70.88 M60.04 M71.3 M32.44 M44.89 M59.59 M 208.21 M

Notizie

Why Catalyst Pharmaceutical (CPRX) is a Top Momentum Stock for the Long-Term

Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term

CPRX or UTHR: Which Is the Better Value Stock Right Now?

Catalyst Pharmaceuticals Q1 Earnings Beat, Firdapse Revenues Rise Y/Y

Gli EPS di Catalyst Pharmaceuticals hanno battuto le aspettative per 0,06$, il fatturato supera le previsioni

Catalyst (CPRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Catalyst Pharmaceutical (CPRX) Surpasses Q1 Earnings and Revenue Estimates

Perrigo Q1 Earnings Surpass Estimates, Sales Miss, Both Fall Y/Y

UTHR Q1 Earnings Miss Estimates, Shares Jump on Strong Outlook

ACAD Q1 Earnings & Revenues Miss Estimates Despite Y/Y Sales Growth

Madrigal Q1 Earnings Beat, MASH Drug Sales Drive Top Line, Stock Up

RXRX Q1 Loss Narrower Than Expected, Revenues Decline Y/Y